Medicofarma Biotech (Poland) Technical Analysis

MDB Stock   0.38  0.03  7.32%   
As of the 2nd of December, Medicofarma Biotech secures the Risk Adjusted Performance of (0.07), mean deviation of 2.6, and Standard Deviation of 4.27. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medicofarma Biotech, as well as the relationship between them. Please verify Medicofarma Biotech mean deviation, information ratio, as well as the relationship between the Information Ratio and potential upside to decide if Medicofarma Biotech SA is priced some-what accurately, providing market reflects its recent price of 0.38 per share.

Medicofarma Biotech Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Medicofarma, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Medicofarma
  
Medicofarma Biotech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Medicofarma Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Medicofarma Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Medicofarma Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Medicofarma Biotech Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Medicofarma Biotech volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Medicofarma Biotech Trend Analysis

Use this graph to draw trend lines for Medicofarma Biotech SA. You can use it to identify possible trend reversals for Medicofarma Biotech as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Medicofarma Biotech price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Medicofarma Biotech Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Medicofarma Biotech SA applied against its price change over selected period. The best fit line has a slop of   0.0032  , which may suggest that Medicofarma Biotech SA market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.4, which is the sum of squared deviations for the predicted Medicofarma Biotech price change compared to its average price change.

About Medicofarma Biotech Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Medicofarma Biotech SA on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Medicofarma Biotech SA based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Medicofarma Biotech price pattern first instead of the macroeconomic environment surrounding Medicofarma Biotech. By analyzing Medicofarma Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Medicofarma Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Medicofarma Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.

Medicofarma Biotech December 2, 2024 Technical Indicators

Most technical analysis of Medicofarma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Medicofarma from various momentum indicators to cycle indicators. When you analyze Medicofarma charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Additional Tools for Medicofarma Stock Analysis

When running Medicofarma Biotech's price analysis, check to measure Medicofarma Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicofarma Biotech is operating at the current time. Most of Medicofarma Biotech's value examination focuses on studying past and present price action to predict the probability of Medicofarma Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicofarma Biotech's price. Additionally, you may evaluate how the addition of Medicofarma Biotech to your portfolios can decrease your overall portfolio volatility.